{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:05:33Z","timestamp":1790816733964,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["821283"],"award-info":[{"award-number":["821283"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013322","name":"European Federation of Pharmaceutical Industries and Associations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.taap.2026.117998","type":"journal-article","created":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T11:35:04Z","timestamp":1786880104000},"page":"117998","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Identification of candidate microRNA biomarkers of mouse cholangiocyte injury by global miRNAome analysis"],"prefix":"10.1016","volume":"516","author":[{"given":"Lawrence","family":"Howell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph P.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiva Seyed","family":"Forootan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Livoti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Ressel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bushell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Goldring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.taap.2026.117998_bb0005","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/clpt.2011.58","article-title":"Case definition and phenotype standardization in drug-induced liver injury","volume":"89","author":"Aithal","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.taap.2026.117998_bb0010","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.tips.2016.11.003","article-title":"Genomics of adverse drug reactions","volume":"38","author":"Alfirevic","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.taap.2026.117998_bb0015","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1053\/jhep.2000.9078","article-title":"The function of alkaline phosphatase in the liver: regulation of intrahepatic biliary epithelium secretory activities in the rat","volume":"32","author":"Alvaro","year":"2000","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.taap.2026.117998_bb0020","doi-asserted-by":"crossref","first-page":"210","DOI":"10.4103\/IJPSYM.IJPSYM_193_19","article-title":"The P value and statistical significance: misunderstandings, explanations, challenges, and alternatives","volume":"41","author":"Andrade","year":"2019","journal-title":"Indian J. Psychol. Med."},{"issue":"2","key":"10.1016\/j.taap.2026.117998_bb0025","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1177\/1091581817752405","article-title":"Accessible miRNAs as novel toxicity biomarkers","volume":"37","author":"Bailey","year":"2018","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.taap.2026.117998_bb0030","article-title":"A new framework for advancing in drug-induced liver injury research. The prospective European DILI registry","author":"Bj\u00f6rnsson","year":"2022","journal-title":"Liver Int."},{"issue":"6","key":"10.1016\/j.taap.2026.117998_bb0035","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2131\/jts.42.715","article-title":"Characterization of a rat model of moderate liver dysfunction based on alpha-naphthylisothiocyanate-induced cholestasis","volume":"42","author":"Bothe","year":"2017","journal-title":"J. Toxicol. Sci."},{"issue":"2","key":"10.1016\/j.taap.2026.117998_bb0040","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/BF02342506","article-title":"Endotoxin tolerance and polymyxin B modify liver damage and cholestasis induced by a single dose of \u03b1-naphthylisothiocyanate in the rat","volume":"66","author":"Calcamuggi","year":"1992","journal-title":"Arch. Toxicol."},{"issue":"2","key":"10.1016\/j.taap.2026.117998_bb0045","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jhep.2015.04.016","article-title":"Drug-induced liver injury: interactions between drug properties and host factors","volume":"63","author":"Chen","year":"2015","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.taap.2026.117998_bb0050","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1177\/1535370217740853","article-title":"In silico modeling to optimize interpretation of liver safety biomarkers in clinical trials","volume":"243","author":"Church","year":"2018","journal-title":"Exp. Biol. Med."},{"issue":"1","key":"10.1016\/j.taap.2026.117998_bb0055","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/1751-2980.12684","article-title":"Serum biomarkers of drug-induced liver injury: current status and future directions","volume":"20","author":"Church","year":"2019","journal-title":"J. Dig. Dis."},{"issue":"1","key":"10.1016\/j.taap.2026.117998_bb0060","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/toxsci\/kfv260","article-title":"Beyond miR-122: identification of microRNA alterations in blood during a time course of hepatobiliary injury and biliary hyperplasia in rats","volume":"150","author":"Church","year":"2016","journal-title":"Toxicol. Sci."},{"issue":"2","key":"10.1016\/j.taap.2026.117998_bb0065","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0041-008X(88)90121-4","article-title":"Early changes in bile duct lining cells and hepatocytes in rats treated with alpha-naphthylisothiocyanate","volume":"93","author":"Connolly","year":"1988","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"8","key":"10.1016\/j.taap.2026.117998_bb0070","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1007\/s10620-016-4121-6","article-title":"Amoxicillin\u2013clavulanate-induced liver injury","volume":"61","author":"Delemos","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.taap.2026.117998_bb0075","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.exer.2013.07.003","article-title":"miRNA and mRNA expression profiling identifies members of the miR-200 family as potential regulators of epithelial\u2013mesenchymal transition in pterygium","volume":"115","author":"Engelsvold","year":"2013","journal-title":"Exp. Eye Res."},{"issue":"1","key":"10.1016\/j.taap.2026.117998_bb0080","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.gastro.2014.03.045","article-title":"Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset","volume":"147","author":"Fontana","year":"2014","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.taap.2026.117998_bb0085","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/liv.14800","article-title":"Rodent models of cholestatic liver disease: a practical guide for translational research","volume":"41","author":"Gijbels","year":"2021","journal-title":"Liver Int."},{"issue":"1","key":"10.1016\/j.taap.2026.117998_bb0090","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1293\/tox.2017-0036","article-title":"Circulating liver-specific microRNAs in cynomolgus monkeys","volume":"31","author":"Iguchi","year":"2018","journal-title":"J. Toxicol. Pathol."},{"issue":"5","key":"10.1016\/j.taap.2026.117998_bb0095","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/0016-5085(89)91695-8","article-title":"Isolation and morphologic characterization of bile duct epithelial cells from normal rat liver","volume":"97","author":"Ishii","year":"1989","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.taap.2026.117998_bb0100","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/toxsci\/kfg125","article-title":"Glutathione depletion exacerbates methylenedianiline toxicity to biliary epithelial cells and hepatocytes in rats","volume":"74","author":"Kanz","year":"2003","journal-title":"Toxicol. Sci."},{"issue":"4","key":"10.1016\/j.taap.2026.117998_bb0105","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/mc.21864","article-title":"Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance","volume":"52","author":"Karakatsanis","year":"2013","journal-title":"Mol. Carcinog."},{"issue":"1","key":"10.1016\/j.taap.2026.117998_bb0110","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/toxsci\/kfac042","article-title":"Evaluation of variability across rat acute oral systemic toxicity studies","volume":"188","author":"Karmaus","year":"2022","journal-title":"Toxicol. Sci."},{"issue":"21\u221222","key":"10.1016\/j.taap.2026.117998_bb0115","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1089\/ten.tea.2013.0021","article-title":"Biliary epithelial cells play an essential role in the reconstruction of hepatic tissue with a functional bile ductular network","volume":"19","author":"Katsuda","year":"2013","journal-title":"Tissue Eng. Part A"},{"issue":"1","key":"10.1016\/j.taap.2026.117998_bb0120","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/toxsci\/kfu269","article-title":"MicroRNA-122: a novel hepatocyte-enriched in vitro marker of drug-induced cellular toxicity","volume":"144","author":"Kia","year":"2014","journal-title":"Toxicol. Sci."},{"issue":"5","key":"10.1016\/j.taap.2026.117998_bb0125","doi-asserted-by":"crossref","first-page":"836","DOI":"10.5009\/gnl15460","article-title":"MicroRNA 141 expression is a potential prognostic marker of biliary tract cancers","volume":"10","author":"Kim","year":"2016","journal-title":"Gut Liver"},{"issue":"1","key":"10.1016\/j.taap.2026.117998_bb0130","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1006\/faat.1995.1074","article-title":"Biliary epithelial cell proliferation following alpha-naphthylisothiocyanate (ANIT) treatment: relationship to bile duct obstruction","volume":"26","author":"Kossor","year":"1995","journal-title":"Fundam. Appl. Toxicol."},{"issue":"5","key":"10.1016\/j.taap.2026.117998_bb0135","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1177\/0192623308320272","article-title":"Time- and dose-based gene expression profiles produced by a bile-duct-damaging chemical, 4,4\u2032-methylene dianiline, in mouse liver in an acute phase","volume":"36","author":"Kwon","year":"2008","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.taap.2026.117998_bb0140","series-title":"Isolation and Culture of Adult Mouse Hepatocytes","first-page":"185","author":"Li","year":"2010"},{"key":"10.1016\/j.taap.2026.117998_bb0145","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.tox.2016.09.020","article-title":"Alpha-naphthylisothiocyanate impairs bile acid homeostasis through AMPK-FXR pathways in rat primary hepatocytes","volume":"370","author":"Li","year":"2016","journal-title":"Toxicology"},{"issue":"2","key":"10.1016\/j.taap.2026.117998_bb0150","first-page":"49","article-title":"MiR-200a\/ZEB1 pathway in liver fibrogenesis of biliary atresia, world academy of science","volume":"11","author":"Liu","year":"2017","journal-title":"Eng. Technol. Int. J. Med. Health Sci."},{"key":"10.1016\/j.taap.2026.117998_bb0155","series-title":"The Clinical Chemistry of Laboratory Animals","author":"Loeb","year":"1999"},{"issue":"2","key":"10.1016\/j.taap.2026.117998_bb0160","first-page":"229","article-title":"A novel MicroRNA signature for Cholestatic drugs in human hepatocytes and its translation into novel circulating biomarkers for drug-induced liver injury patients","volume":"173","author":"L\u00f3pez-Riera","year":"2020","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2026.117998_bb0165","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1471-2164-12-64","article-title":"Pre-processing and differential expression analysis of Agilent microRNA arrays using the AgiMicroRna Bioconductor library","volume":"12","author":"Lopez-Romero","year":"2011","journal-title":"BMC Genomics"},{"issue":"4 Pt B","key":"10.1016\/j.taap.2026.117998_bb0170","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.bbadis.2017.06.027","article-title":"Animal models of biliary injury and altered bile acid metabolism","volume":"1864","author":"Mariotti","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"3","key":"10.1016\/j.taap.2026.117998_bb0175","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1055\/s-2002-34501","article-title":"Functional heterogeneity of cholangiocytes","volume":"22","author":"Marzioni","year":"2002","journal-title":"Semin. Liver Dis."},{"issue":"10","key":"10.1016\/j.taap.2026.117998_bb0180","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1681\/ASN.2015040422","article-title":"MicroRNA-196a\/b mitigate renal fibrosis by targeting TGF-beta receptor 2","volume":"27","author":"Meng","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.taap.2026.117998_bb0185","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s40520-014-0296-x","article-title":"Elevation of serum alkaline phosphatase (ALP) level in postmenopausal women is caused by high bone turnover","volume":"27","author":"Mukaiyama","year":"2015","journal-title":"Aging Clin. Exp. Res."},{"issue":"2","key":"10.1016\/j.taap.2026.117998_bb0190","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/hep.20548","article-title":"Serum alanine aminotransferase in skeletal muscle diseases","volume":"41","author":"Nathwani","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2026.117998_bb0195","doi-asserted-by":"crossref","DOI":"10.1002\/jat.4144","article-title":"Plasma miR-218a-5p as a biomarker for acute cholestatic liver injury in rats and investigation of its pathophysiological roles","author":"Oda","year":"2021","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.taap.2026.117998_bb0200","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12916-016-0553-2","article-title":"Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature","volume":"14","author":"Onakpoya","year":"2016","journal-title":"BMC Med."},{"issue":"8","key":"10.1016\/j.taap.2026.117998_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/cells10081846","article-title":"Farnesoid X receptor as target for therapies to treat cholestasis-induced liver injury","volume":"10","author":"Petrescu","year":"2021","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.taap.2026.117998_bb0210","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1002\/hep.27715","article-title":"Liver alkaline phosphatase: a missing link between choleresis and biliary inflammation","volume":"61","author":"Poupon","year":"2015","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.taap.2026.117998_bb0215","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.fertnstert.2015.06.029","article-title":"Circulating miR-200\u2013family micro-RNAs have altered plasma levels in patients with endometriosis and vary with blood collection time","volume":"104","author":"Rekker","year":"2015","journal-title":"Fertil. Steril."},{"issue":"4","key":"10.1016\/j.taap.2026.117998_bb0220","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00228-016-2183-1","article-title":"Role of miRNA and its potential as a novel diagnostic biomarker in drug-induced liver injury","volume":"73","author":"Sanjay","year":"2017","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.taap.2026.117998_bb0225","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-28748-5","article-title":"Stability of circulating Exosomal miRNAs in healthy subjects","volume":"8","author":"Sanz-Rubio","year":"2018","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.taap.2026.117998_bb0230","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"issue":"11","key":"10.1016\/j.taap.2026.117998_bb0235","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1007\/s00204-021-03150-9","article-title":"Systems analysis of miRNA biomarkers to inform drug safety","volume":"95","author":"Schofield","year":"2021","journal-title":"Arch. Toxicol."},{"issue":"1","key":"10.1016\/j.taap.2026.117998_bb0240","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/0300985815591076","article-title":"Evaluation of miR-122 as a serum biomarker for hepatotoxicity in investigative rat toxicology studies","volume":"53","author":"Sharapova","year":"2015","journal-title":"Vet. Pathol."},{"issue":"2","key":"10.1016\/j.taap.2026.117998_bb0245","first-page":"134","article-title":"Update on acute liver failure","volume":"21","author":"Singanayagam","year":"2015","journal-title":"Curr. Opin. Crit. Care"},{"issue":"2","key":"10.1016\/j.taap.2026.117998_bb0250","first-page":"175","article-title":"Extracellular\/circulating MicroRNAs: release mechanisms, functions and challenges","volume":"10","author":"Sohel","year":"2016","journal-title":"Achieve. Life Sci."},{"issue":"1","key":"10.1016\/j.taap.2026.117998_bb0255","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1089-3261(03)00136-3","article-title":"Serum enzymes associated with cholestasis","volume":"8","author":"Sotil","year":"2004","journal-title":"Clin. Liver Dis."},{"issue":"5","key":"10.1016\/j.taap.2026.117998_bb0260","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1002\/hep.24538","article-title":"Circulating microRNAs as potential markers of human drug-induced liver injury","volume":"54","author":"Starkey Lewis","year":"2011","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.taap.2026.117998_bib346","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/ar.20664","article-title":"Functional anatomy of normal bile ducts","volume":"291","author":"Strazzabosco","year":"2008","journal-title":"Anat. Rec. (Hoboken)"},{"issue":"8","key":"10.1016\/j.taap.2026.117998_bb0265","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/hep4.1088","article-title":"Drug-induced cholestasis","volume":"1","author":"Sundaram","year":"2017","journal-title":"Hepatol. Commun."},{"issue":"10","key":"10.1016\/j.taap.2026.117998_bb0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111424","article-title":"Serum MicroRNAs as potential biomarkers of primary biliary cirrhosis","volume":"9","author":"Tan","year":"2014","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.taap.2026.117998_bb0275","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/toxsci\/kfp020","article-title":"ANIT-induced intrahepatic cholestasis alters hepatobiliary transporter expression via Nrf2-dependent and independent signaling","volume":"108","author":"Tanaka","year":"2009","journal-title":"Toxicol. Sci."},{"issue":"9","key":"10.1016\/j.taap.2026.117998_bb0280","article-title":"Intrahepatic bile ducts guide establishment of the intrahepatic nerve network in developing and regenerating mouse liver","volume":"145","author":"Tanimizu","year":"2018","journal-title":"Development"},{"issue":"9","key":"10.1016\/j.taap.2026.117998_bb0285","doi-asserted-by":"crossref","first-page":"E928","DOI":"10.21037\/jtd.2016.08.16","article-title":"P value interpretations and considerations","volume":"8","author":"Thiese","year":"2016","journal-title":"J. Thorac. Dis."},{"issue":"5","key":"10.1016\/j.taap.2026.117998_bb0290","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1080\/1354750X.2016.1269131","article-title":"A longitudinal assessment of miR-122 and GLDH as biomarkers of drug-induced liver injury in the rat","volume":"22","author":"Thulin","year":"2017","journal-title":"Biomarkers"},{"issue":"9","key":"10.1016\/j.taap.2026.117998_bb0295","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1111\/bcp.13282","article-title":"MicroRNA-122 can be measured in capillary blood which facilitates point-of-care testing for drug-induced liver injury","volume":"83","author":"Vliegenthart","year":"2017","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.taap.2026.117998_bb0300","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/jcp.25056","article-title":"MicroRNA as biomarkers and diagnostics","volume":"231","author":"Wang","year":"2016","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.taap.2026.117998_bb0305","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.tox.2017.05.012","article-title":"Glycyrrhizin and glycyrrhetinic acid inhibits alpha-naphthyl isothiocyanate-induced liver injury and bile acid cycle disruption","volume":"386","author":"Wang","year":"2017","journal-title":"Toxicology"},{"issue":"13","key":"10.1016\/j.taap.2026.117998_bb0310","doi-asserted-by":"crossref","first-page":"6162","DOI":"10.1073\/pnas.1814139116","article-title":"Injured liver-released miRNA-122 elicits acute pulmonary inflammation via activating alveolar macrophage TLR7 signaling pathway","volume":"116","author":"Wang","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"6","key":"10.1016\/j.taap.2026.117998_bb0315","doi-asserted-by":"crossref","first-page":"R83","DOI":"10.1186\/gb-2014-15-6-r83","article-title":"Conserved microRNA editing in mammalian evolution, development and disease","volume":"15","author":"Warnefors","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.taap.2026.117998_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2022.153256","article-title":"The role of the farnesoid X receptor in quadruple anti-tuberculosis drug-induced liver injury","volume":"476","author":"Wen","year":"2022","journal-title":"Toxicology"},{"issue":"2","key":"10.1016\/j.taap.2026.117998_bb0325","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030250","article-title":"Plasma MicroRNA profiles in rat models of hepatocellular injury, cholestasis, and steatosis","volume":"7","author":"Yamaura","year":"2012","journal-title":"PLoS ONE"},{"issue":"9","key":"10.1016\/j.taap.2026.117998_bb0330","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/aps.2016.86","article-title":"Sweroside ameliorates \u03b1-naphthylisothiocyanate-induced cholestatic liver injury in mice by regulating bile acids and suppressing pro-inflammatory responses","volume":"37","author":"Yang","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.taap.2026.117998_bb0335","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2017.00256","article-title":"SRT1720 alleviates ANIT-induced cholestasis in a mouse model","volume":"8","author":"Yu","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.taap.2026.117998_bb0340","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/MPG.0b013e318264e648","article-title":"Circulating MicroRNA is a biomarker of biliary atresia","volume":"55","author":"Zahm","year":"2012","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"6","key":"10.1016\/j.taap.2026.117998_bb0345","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1002\/hep.25905","article-title":"Promotion of liver regeneration\/repair by farnesoid X receptor in both liver and intestine in mice","volume":"56","author":"Zhang","year":"2012","journal-title":"Hepatology"}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X26002942?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X26002942?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:48:07Z","timestamp":1790815687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X26002942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":70,"alternative-id":["S0041008X26002942"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2026.117998","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of candidate microRNA biomarkers of mouse cholangiocyte injury by global miRNAome analysis","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2026.117998","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117998"}}